Skip to main content
. 2013 Dec 17;170(8):1459–1581. doi: 10.1111/bph.12445
Nomenclature C3a receptor C5a1 receptor C5a2 receptor
HGNC, UniProt C3AR1, Q16581 C5AR1, P21730 C5AR2, Q9P296
Principal transduction Gi/o, Gz Gi/o, Gz, G16 (Buhl et al., 1993)
Rank order of potency C3a > C5a 653 C5a, C5a des-Arg (C5) > C3a 653
Endogenous agonists (pKi) RP-S19 (RPS19, P39019) 675
Selective agonists (pKi) E7 (pEC50 8.7) 654 N-methyl-Phe-Lys-Pro-D-Cha-Cha-D-Arg-CO2H (pIC50 7.6) 664,666
Selective antagonists (pKi) SB290157 (pIC50 7.6) 652 CHIPS (pKd 9.0) 670, W54011 (8.7) 672, AcPhe-Orn-Pro-D-Cha-Trp-Arg (pIC50 7.9) 674, N-methyl-Phe-Lys-Pro-D-Cha-Trp-D-Arg-CO2H (pIC50 7.2) 666
Radioligands (Kd) [125I]C3a (human) (Agonist, Full agonist) (3.85x10-9 M) 657 [125I]C5a (human) (Agonist, Full agonist) (2x10-9 M) 661 [125I]C5a (human) (Agonist, Full agonist)
Comment Binds C5a complement factor, but appears to lack G protein signalling and has been termed a decoy receptor 671